Enfeira 500mg Injection
Marketer
Zydus Cadila
Salt Composition
Rituximab (500mg)
Overview Enfeira 500mg Injection
Rituximab 500mg Injection treats various conditions including non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangiitis. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits might not be apparent immediately; discontinue use only under your doctor's guidance. Common side effects include headache, fatigue, swelling, infections, and alopecia. This medication can lower blood cell counts, increasing infection risk, necessitating regular blood tests, including hepatitis B monitoring. Prior to commencing treatment, inform your doctor of any pre-existing heart or liver conditions, upcoming surgeries or vaccinations, or concurrent medications, especially those for infections. Interactions with other drugs are possible; disclose all medications to your physician. This injection is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is essential throughout treatment.
Uses of Enfeira 500mg Injection
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin lymphoma.
Major Benefits of Enfeira 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Enfeira 500mg Injection:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Enfeira 500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Enfeira 500mg Injection works:
The injectable medication Enfeira 500mg is a monoclonal antibody therapy. Its mechanism of action involves neutralizing the aberrant activity of B lymphocytes, thereby offering therapeutic benefit in rheumatoid arthritis and selected malignancies.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Enfeira 500mg Injection and alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Enfeira 500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Enfeira 500mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of a 500mg Enfeira Injection on driving ability is undetermined. Refrain from operating a vehicle should you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Enfeira 500mg Injection in individuals with impaired kidney function appears to pose minimal risk. Preliminary evidence indicates that dosage modification may not be necessary. However, physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Enfeira 500mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised. Enfeira 500mg Injection is contraindicated in patients experiencing active liver disease or a history of viral hepatitis due to the potential for infection recurrence.
What if you forget to take Enfeira 500mg Injection :
Should you forget a scheduled Enfeira 500mg Injection, seek your physician's advice.
Facts to Know About Enfeira 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
| Action Class | CD20-targeting agent |
3,018 People bought this recently